The Veeda Newsletter

   ISSUE 2 :  FEBRUARY 2019

Generic Drugs

FDA Releases 74 Product-
Specific Guidance's

INDIAN PHARMA

New rules sweeten
the deal for clinical
trials by Indian
pharma cos

REGULATORY

FDA Policies
Support Shift to
Decentralized Clinical
Trials

Clinical Research

The Rise of Orphan
Drugs: A New Paradigm
for the Future

FINANCIALS

Bharat Biotech eyes
largest rabies vaccine
maker tag after
GSK deal

M&A NEWS

5 Top Drug/Biotech
Merger & Acquisition
Targets for
2019

www.veedacr.com
info@veedacr.com
Contact Us